Grade 3 or 4 adverse experiences by group in more than 1 patient
| Adverse experience . | Group 1; n = 13 . | Group 2; n = 12 . | Group 3; n = 12 . | All patients; n = 37 . | ||||
|---|---|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | n . | % . | |
| Thrombocytopenia | 1 | 8 | 1 | 8 | 5 | 42 | 7 | 19 |
| Anemia | 1 | 8 | 2 | 17 | 0 | 0 | 3 | 8 |
| Deep vein thrombosis | 0 | 0 | 3 | 25 | 0 | 0 | 3 | 8 |
| Dehydration | 1 | 8 | 0 | 0 | 2 | 17 | 3 | 8 |
| Pyrexia | 0 | 0 | 3 | 25 | 0 | 0 | 3 | 8 |
| Hypotension | 0 | 0 | 2 | 17 | 0 | 0 | 2 | 5 |
| Pulmonary embolism | 0 | 0 | 2 | 17 | 0 | 0 | 2 | 5 |
| Sepsis | 0 | 0 | 1 | 8 | 1 | 8 | 2 | 5 |
| Adverse experience . | Group 1; n = 13 . | Group 2; n = 12 . | Group 3; n = 12 . | All patients; n = 37 . | ||||
|---|---|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | n . | % . | |
| Thrombocytopenia | 1 | 8 | 1 | 8 | 5 | 42 | 7 | 19 |
| Anemia | 1 | 8 | 2 | 17 | 0 | 0 | 3 | 8 |
| Deep vein thrombosis | 0 | 0 | 3 | 25 | 0 | 0 | 3 | 8 |
| Dehydration | 1 | 8 | 0 | 0 | 2 | 17 | 3 | 8 |
| Pyrexia | 0 | 0 | 3 | 25 | 0 | 0 | 3 | 8 |
| Hypotension | 0 | 0 | 2 | 17 | 0 | 0 | 2 | 5 |
| Pulmonary embolism | 0 | 0 | 2 | 17 | 0 | 0 | 2 | 5 |
| Sepsis | 0 | 0 | 1 | 8 | 1 | 8 | 2 | 5 |